Search Results for "BIAL Pharmaceuticals"

21:40 EST 16th January 2017 | BioPortfolio

Matching Channels


Located in the north-east corner of the USA, Massachusetts, has the third highest GDP of any state in America and is also a hotspot for the biotechnology industry. In addition to the globally renown...

The Top 100 Drugs

The pharmaceutical industry is massive, both in range of products and in financial values. These are the top 200 drugs (ranked in descending order according to total sales in 20010, $), and the co...

Datamonitor - aims to help its clients operating in the pharmaceuticals, healthcare and biotechnology fields, offering world-leading products and services to meet the challenges of this rapidly evolving marketplace

The Datamonitor Group aims to help its clients operating in the pharmaceuticals, healthcare and biotechnology fields, offering world-leading products and services to meet the challenges of this rapi...


Surrounded by the Great Lakes in the north east of the US, Michigan hosts many high profile biotechnology companies and has become an industry hotbed. In 1993 MichBio was formed, as an industry tr...


Covidien is the 9th largest global medical device company with annual sales in 2010 of almost $8 billion. Covidien was originally Tyco Healthcare, until June 2007, and has seen year-on-year growth s...

Matching News

UK launch for Bial’s Parkinson’s drug

Patients with Parkinson's disease in the UK can now potentially access a new option to treat motor fluctuations with the launch of Bial's Ongentys across the country.

Portugal’s Bial launches Ongentys for Parkinson´s disease in UK

Bial says that its Ongentys (opicapone) has now been launched in the UK for the treatment of adult Parkinson´s…

NeuroBreak: Spinraza's $750K Price Tag; Bial Skipped PD Data

(MedPage Today) -- News and commentary from the world of neurology and neuroscience

FDA: Bial-Portela's FAAH inhibitor has "unique toxicity"

In its safety review of fatty acid amide hydrolase (FAAH) inhibitors, FDA concluded that BIA 10-2474 from Bial-Portela & Ca. S.A. (S. Mamede do Coronado, Portugal) "exhibits a unique toxicity that doe...

Bial Portela Ca, S.A. Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250

SummaryBial Portela Ca, S.A. BIAL is a pharmaceutical company that discovers, develops and provides therapeutic solutions. The company offers products such as antiinflammatories, antidiabetics, card...

New treatment option for Parkinson’s disease launched in the UK

Drug company BIAL Pharm UK has launched opicapone (Ongentys), a new drug to improve mobility in some adult patients with Parkinson’s disease, for use in the UK. 

French clinical trial tragedy did not check all data

There have been new revelations regarding the fatal French clinical trial that occurred in January of this year. Nature reports that in a conference call the company behind the trial, Portuguese compa...

M&As this week: Dendreon Pharmaceuticals, Agile Pharma, Takeda Pharmaceutical Company

Valeant Pharmaceuticals International subsidiary Dendreon Pharmaceuticals will be acquired by Sanpower Group.

Matching PubMed Articles

Biotransformation of pharmaceuticals by ammonia oxidizing bacteria in wastewater treatment processes.

Pharmaceutical residues could potentially pose detrimental effects on aquatic ecosystems and human health, with wastewater treatment being one of the major pathways for pharmaceuticals to enter into t...

Progress Confirmed for Pharmaceuticals in 2016.


Temporal and spatial behavior of pharmaceuticals in Narragansett Bay, Rhode Island, United States.

The behavior and fate of pharmaceutical ingredients in coastal marine ecosystems is not well understood. To address this, the spatial and temporal distribution of 15 high volume pharmaceuticals were m...

Announcing the 2016 Pharmaceuticals Travel Award for Young Investigators.

For the first time in its short history, our journal is able, this year, to support a young researcher in the field of medicinal chemistry by offering a travel grant of 800 CHF.[...].

Photosynthetic sensitivity of phytoplankton to commonly used pharmaceuticals and its dependence on cellular phosphorus status.

Recently pharmaceuticals have become significant environmental pollutants in aquatic ecosystems, that could affect primary producers such as microalgae. Here we analyzed the effect of pharmaceuticals ...

Search Whole site using Google

Quick Search
Advertisement Advertisement